Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More General business news Saint-Gobain expands in Indian market with acquisition of Menkol Industries Saint-Gobain, a global leader in sustainable habitat solutions, has recently announced its acquisition of Menkol Industries Private Limited,… byPallavi MadhirajuDecember 7, 2023